Trial Phase: Syndemic Adapted Medly Uganda

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

Also called NCT07525271

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07525271
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Uganda (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07525271. Randomized; no masking; primary purpose treatment. Start 2026-09-14 (actual); primary completion 2028-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial Phase: Syndemic Adapted Medly Uganda
Acronym
SAMU
Condition
Mental Health
Intervention (Device)
Syndemic-Adapted Medly Uganda (SAMU)
Lead sponsor
Yale University (class: other)
Collaborator
National Institute of Mental Health (NIMH) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07525271
Content hash
342521c35e6a6149bdbebd75423c54564535d83fdd8040398deede4702087f48